William J. Binder
NationalityAmerican
Occupation(s)Facial plastic and reconstructive surgeon
Known forUse of Botox as chronic migraine cure
Websitedoctorbinder.com

William J. Binder is an American facial plastic surgeon. He is best known for his 1992 discovery of the use of Botox to alleviate chronic migraine.[1][2]

Biography

Binder holds an M.D. degree from the University of Medicine and Dentistry of New Jersey.[3] He was elected as a member of the Board of Directors of the American Academy of Facial Plastic and Reconstructive Surgery, where he also serves as a National Board Examiner.

He is a member of the National Review Committee for the American Academy of Neurology Therapeutics and Technologies Subcommittee on the Assessment of Botulinum Toxin Therapy and also is an adjunct reviewer for the Archives of Facial Plastic Surgery Journal.

Binder is board certified by both the American Academy of Facial Plastic and Reconstructive Surgery and the American Board of Otolaryngology and Head and Neck Surgery. He has published around 70 articles in national medical and surgical journals. He has edited three textbooks in Facial Plastic Surgery, Head and Neck Surgery, and Otolaryngology.

He speaks and lectures on various aspects of facial plastic surgery including rhinoplasty and a multi-level concept of facelift surgery.[4][5]

Binder has filed 15 U.S. and European patents in the area of Custom Plastic Surgery Implants, Method for Reduction of Migraine Headache Pain, Flexible support wrap, and Anesthesia conduit.[6]

In 1992, Binder discovered the use of Botox to alleviate the suffering of those with chronic migraine headaches.[7][8] He reported that patients who had cosmetic injections around the face reported relief from chronic headache.[9] This was initially thought to be an indirect effect of reduced muscle tension, but it is now known that the toxin inhibits release of peripheral nociceptive neurotransmitters, suppressing the central pain processing systems responsible for migraine headache.[10][11] In 2010, the FDA approved intramuscular botulinum toxin injections for prophylactic treatment of chronic migraine headache.[12]

References

  1. "11 Surprising Uses for Botox". Time. Retrieved 2017-05-12.
  2. "Botox Is the Drug for All Health Problems-Yet Consider the Side Effects Too". Latin Post. 2017-01-06. Archived from the original on 2017-01-07. Retrieved 2017-05-12.
  3. "Why more 20-somethings are getting Botox". Archived from the original on 2017-06-13. Retrieved 2017-06-04.
  4. Staff, Hollywood Life (15 October 2010). "Photos! Docs Tell Us 'The Real Housewives Of Beverly Hills' ALL Appear To Have Had Plastic Surgery: Botox, Implants & More!". Archived from the original on 25 December 2016. Retrieved 4 June 2017.
  5. hollywoodlifeintern (22 December 2010). "Heidi Montag Regrets Shocking Plastic Surgery! See Her Scars Plus Other Stars Who Went Under Knives in 2010!". Archived from the original on 10 June 2017. Retrieved 4 June 2017.
  6. "William J. Binder Inventions, Patents and Patent Applications - Justia Patents Search". patents.justia.com. Retrieved 2024-01-07.
  7. Post, Latin (6 January 2017). "Botox Is The Drug For All Health Problems-Yet Consider The Side Effects Too". Archived from the original on 7 January 2017. Retrieved 12 May 2017.
  8. "Botox: mucho más que cosmética". www.mercado.com.ar. 10 January 2017. Archived from the original on 3 June 2017. Retrieved 4 June 2017.
  9. Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM (December 2000). "Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study". Otolaryngology–Head and Neck Surgery. 123 (6): 669–76. doi:10.1067/mhn.2000.110960. PMID 11112955. S2CID 24406607.
  10. Jackson JL, Kuriyama A, Hayashino Y (April 2012). "Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis". JAMA. 307 (16): 1736–45. doi:10.1001/jama.2012.505. PMID 22535858.
  11. Ramachandran R, Yaksh TL (September 2014). "Therapeutic use of botulinum toxin in migraine: mechanisms of action". British Journal of Pharmacology. 171 (18): 4177–92. doi:10.1111/bph.12763. PMC 4241086. PMID 24819339.
  12. "FDA Approves Botox to Treat Chronic Migraines". WebMD. Archived from the original on 5 May 2017. Retrieved 12 May 2017.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.